DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
This is a 100% increase over the number of companies inspected in the previous quarter, when two companies received two inspections.
Most of the companies inspected at the time were involved in the Biologics and Food and Cosmetics sectors. Both the Devices and Drugs sectors sectors tied for second most common type.
There were three companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Blood Connection, Inc. | Biologics | 02/27/2024 | No Action Indicated (NAI) |
| Fresh Chef Foods, Inc. | Food and Cosmetics | 03/07/2024 | No Action Indicated (NAI) |
| Greenville Hospital System- IRB | Biologics | 03/29/2024 | No Action Indicated (NAI) |
| Greenville Hospital System- IRB | Devices | 03/29/2024 | No Action Indicated (NAI) |
| Greenville Hospital System- IRB | Drugs | 03/29/2024 | No Action Indicated (NAI) |
| Gusto Seafood, Ltd. | Food and Cosmetics | 01/19/2024 | Voluntary Action Indicated (VAI) |
Alerts Sign-up